Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jan;53(1):192-193.
doi: 10.1111/apt.16165.

Editorial: pharmacodynamics of potassium-competitive acid blockers: comparing apples with apples - and with oranges. Authors' reply

Jung Sunwoo  1 , Ji Yeon Nam  2 , Bongtae Kim  2 , Geun Seog Song  2 , SeungHwan Lee  1
Affiliations
Editorial

Editorial: pharmacodynamics of potassium-competitive acid blockers: comparing apples with apples - and with oranges. Authors' reply

Jung Sunwoo et al. Aliment Pharmacol Ther. 2021 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Howden CW. Editorial: pharmacodynamics of potassium-competitive acid blockers: comparing apples with apples - and with oranges. Aliment Pharmacol Ther. 2020; 53:190-191.
    1. Sunwoo J, Ji SC, Oh J, et al. Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects. Aliment Pharmacol Ther. 2020;52:1640-1647.
    1. Kagami T, Sahara S, Ichikawa H, et al. Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP 2C19 genotype. Aliment Pharmacol Ther. 2016;43:1048-1059.
    1. Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects-a randomised open-label cross-over study. Aliment Pharmacol Ther. 2015;42:719-730.
    1. Lee KJ, Son BK, Kim GH, et al. Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis. Aliment Pharmacol Ther. 2019;49:864-872.